Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review
Agnieszka Kopystecka, Rafał Patryn, Magdalena Leśniewska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9342-9342
Open Access | Times Cited: 18

Showing 18 citing articles:

Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 33
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
Da Xu, Hongwei Wang, Qun Ma, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancer
Ji Shi, Xu Zhu, Jun‐Bo Yang
World Journal of Hepatology (2025) Vol. 17, Iss. 1
Closed Access | Times Cited: 1
Extracellular Vesicles as Liquid Biopsy Biomarkers across the Cancer Journey: From Early Detection to Recurrence
Sagar Rayamajhi, Jared Sipes, Ashley L. Tetlow, et al.
Clinical Chemistry (2024) Vol. 70, Iss. 1, pp. 206-219
Closed Access | Times Cited: 11
Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinoma
Sana Rashid, Yingchuan Sun, Umair Ali Khan Saddozai, et al.
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 2, pp. 195-214
Open Access | Times Cited: 10
Circulating Tumor DNA Profiling in Liver Transplant for Hepatocellular Carcinoma, Cholangiocarcinoma, and Colorectal Liver Metastases: A Programmatic Proof of Concept
Hanna Hong, Chase J. Wehrle, Mingyi Zhang, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 927-927
Open Access | Times Cited: 7
Assessing the Causal Effect of Circulating Protein‐To‐Protein Ratio on the Risk of Morbidity of Hepatocellular Carcinoma
Qiuyuan Yue, Xiaoxia Li, Xiang Wan, et al.
Cancer Medicine (2025) Vol. 14, Iss. 1
Open Access
Combining Liver-Directed and Immunotherapy in Advanced Hepatocellular Carcinoma: A Review and Future Directions
Pranav Kumar, Chase J. Wehrle, Keyue Sun, et al.
Surgical Oncology Insight (2024), pp. 100100-100100
Open Access | Times Cited: 3
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Soo Young Hwang, Pojsakorn Danpanichkul, Vatche G. Agopian, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 3
Methylated ctDNA Quantification: Noninvasive Approach to Monitoring Hepatocellular Carcinoma Burden
Isabella Angeli-Pahim, Anastasia Chambers, Sergio Duarte, et al.
Journal of the American College of Surgeons (2023) Vol. 238, Iss. 4, pp. 770-778
Closed Access | Times Cited: 7
Utility of circulating tumor DNA in secondary liver malignancies: What we know and what is to come
Chase J. Wehrle, Noah X. Tocci, Keyue Sun, et al.
Journal of Surgical Oncology (2024)
Open Access
Circulating tumor DNA in management of primary liver malignancy: A review of the literature and future directions
Noah X. Tocci, Chase J. Wehrle, Keyue Sun, et al.
Journal of Surgical Oncology (2024)
Open Access
An overview of risk assessment and monitoring of malignant transformation in cirrhotic nodules
Zhun Xiao, Fangming Yang, Zheng Liu, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver
Luca Marzi, Andrea Mega, C Turri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11676-11676
Open Access
Hepatocellular Carcinoma Surveillance Strategies: Major Guidelines and Screening Advances
Guan Wu, Nojan Bajestani, Nooruddin Pracha, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3933-3933
Open Access
Recent Advances in Electrochemical Detection Methods for Liver Cancer Biomarkers
Jingjing Du, Hui Tao
International Journal of Electrochemical Science (2024), pp. 100921-100921
Open Access
Non‐Invasive Tumor‐Naïve Minimal Residual Disease Detection of Liver Cancer by Incorporating Circulating Tumor DNA Features and Alpha‐Fetoprotein: A Prospective Study
Qingqi Ren, Shiyong Li, Guolin Zhong, et al.
Cancer Medicine (2024) Vol. 13, Iss. 24
Open Access
Diagnostic lncRNA high expression for liver patients prognosis and medication guidance: a systematic review and meta-analysis
Hengzhou Zhu, Haoyan Chen, Xiaodan Zhu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1

Scroll to top